The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson’s Disease-Reference-Cited by-同舟云学术

The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson’s Disease

Author:

Tang Xu¹,Xing Shuaishuai¹,Ma Mingkang¹,Xu Ziwei¹,Guan Qianwen¹,Chen Yuting¹,Feng Feng²³,Liu Wenyuan¹,Chen Tingkai¹,Chen Yao⁴^ORCID,Sun Haopeng¹^ORCID

Affiliation:

1. School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China

2. Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, People’s Republic of China

3. Jiangsu Food and Pharmaceuticals Science College, Institute of Food and Pharmaceuticals Research, Huai’an 223005, People’s Republic of China

4. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, People’s Republic of China

Funder

Qinglan Project of Jiangsu Province of China

???333 Project??? of Jiangsu Province

Natural Science Foundation of Jiangsu Province

Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

Reference175 articles.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献